Wes Cetnarowski MD
Ladera Ranch,USA
Summary
Dynamic C-Suite Executive, Board Director, and Committee Chair recognized as a transformative leader adept at navigating complex challenges with unwavering perseverance and a focus on achieving success in high-growth healthcare sectors, including Medtech and BioPharma. Expertise includes executive leadership, operations management, and strategic decision-making, with a proven track record in fostering partnerships across healthcare providers and pharmaceutical industries. Key accomplishments include spearheading innovative R&D initiatives, enhancing compliance frameworks, and driving significant cost reductions in clinical trials through strategic optimization. Knowledgeable Physician-Scientist with a strong foundation in delivering strategic consulting solutions, demonstrating exceptional capabilities in stakeholder management and analytical problem-solving to enhance operational efficiency.
Overview
34
34
years of professional experience
1
1
Certification
Work History
Senior Consultant & Fractional/Contract Resource
Wes Cetnarowski MD
07.2024 - Current
- Sectors – Pharma, Biologics, Medical Device, Compounding Pharmacy, Nutritional Supplements, OTC Consumer Products.
- An experienced senior executive, leading in innovation, business development, medical affairs, clinical development, regulatory affairs, quality compliance and risk management, setting high organizational and project success benchmarks.
- Analyze market trends and competitive landscape to inform strategic recommendations for clients across various Biotech sectors.
- Develop strategic frameworks for assessing client needs, resulting in tailored solutions and improved service delivery.
- Lead cross-functional teams to implement process improvements, enhancing operational efficiency and target goals.
Senior Vice President Scientific Affairs, Chief Medical Officer
BBraun Medical Inc., Aesculap Inc., and CAPS Pharmacies
01.2014 - 06.2024
- Responsible for providing strategic direction and leadership for regulatory Affairs, Medical Affairs, Quality Assurance, Clinical Development, Publication and Information Services, Drug Safety, Compounding Pharmacies, and Biostatistics across Medical Device, Nutritionals and Injectable drug Divisions. Delivered near and long term strategies and tactics to protect and optimize company products. Senior scientist in the US and member of the Executive Leadership and Board of Directors.
- Redesigned operations across device and drug franchises to deliver focused, value add registration activities, investigator-initiated studies, medical liaison services and publications. Key therapeutic areas of pain, anti-infectives, parenteral nutrition.
- Initiated Quality and Compliance activities and monitoring systems to ensure protection and validity of engineering, manufacturing, and scientific activities across all franchises.
- Delivered novel KOL interaction and services programs to optimize product advocacy and share of scientific voice.
- Directed cross-functional teams to develop and implement strategic initiatives, enhancing operational efficiency.
- Fostered organizational growth through innovative business development strategies and partnerships.
- Collaborated with executive leadership team members on long-term strategic planning that ensured sustainable success for the company.
- Created innovation platform for continual updating and improvement of product labeling to support claims.
- Board of Directors, BBraun Medical Inc., Bethlehem PA.(Retired)
Senior Vice President, Global Research & Development
Bayer HealthCare, Specialty Pharma & Consumer Care
01.2006 - 01.2013
- Responsible for full scope of research and development activities globally consisting of formulation, analytical, pre-clinical, clinical development and medical affairs, regulatory affairs, drug safety, project management and innovation departments. Responsible for annual budget of greater than 320MM through 9 direct and 400 indirect reports globally.
- Increased pipeline NPV four-fold with the implementation of new strategy, processes, goals, and efficiencies resulting in pipeline clinical development clinical development programs in thousands of patients.
- Created best in class innovation process and group to evaluate and implement clinical development/medical affairs strategies, new product technologies, ingredients, dose forms, combinations, packaging, Rx-OTC switch and non medicated therapies.
- Created best in class regulatory compliance system globally as a business protection measure – 1200 formulations, 134 country registrations, and greater than 200 manufacturing sites.
- Founder of USA Medical Affairs.
- Key management committee member and Chief Medical Officer for Division.
Vice President Medical Affairs
Allergan, LLC
01.2000 - 01.2006
- Founder of Allergan Medical Affairs.
- Responsible for the creation and execution of Medical Affairs Department strategies and plans for all products. Focus on neurology, dermatology and ophthalmology. Managed the department and budget to successfully support the creation of company sponsored pilot trials, investigator initiated trials, drug safety collection and analysis, product medical information, KOL development, CME programs, and publication analysis and planning.
- Successfully created and implemented a vision to build an industry-recognized best-in-class Medical Affairs/MSL Department.
- Led strategic initiatives to enhance product portfolio and drive market expansion.
- Track record of successful change management and organizational scaling.
- Directly responsible for Medical Affairs product support yielding marked product growth across all therapeutic areas.
- Acknowledged as industry leader in Medical Affairs regulatory compliance.
- Spearheaded organizational restructuring initiatives, streamlining operations and reducing overhead costs.
- Ensured regulatory compliance at all times by implementing robust internal controls systems coupled with proactive monitoring mechanisms.
Senior Medical Director & Global Head - Dermatology, Gastroenterology, Complementary Medicine and Rx-OTC Compounds
Warner Lambert Company
01.1992 - 01.2000
- Responsibility for Clinical Research and Medical Affairs department activities for company marketed products, NDA compounds, and Rx-to-OTC switch candidates. Senior member of R&D management and leader, global product development in personal care, dermatology, complementary medicine and GI areas, providing strategic planning and direction in those areas. Strong role in stakeholder development and continuous procurement of medical and business/competitive intelligence. Critical continuous interaction with, and medical advisor to Regulatory Affairs, Statistics, Marketing Research, Marketing, Sales, Legal, and Public Affairs departments. Accomplishments include H2RA switch, multiple SNDAs, healing and anti-scarring development, and homeopathic/botanical drug development to support business goals.
Education
Bachelor of Science - Pre-med studies
McMaster University
Hamilton, Ontario, CanadaBoard Eligible
American Academy of Family Practice
Board Certified in Pharmaceutical Medical Affairs
Accreditation Council for Medical Affairs
undefined
IllinoisMD -
American University of The Caribbean (AUC)
Northern AntillesMaster of Science - Clinical Internship
University of Illinois Affiliated Hospital System
Chicago, IllinoisMaster of Science - Family Practice Residency
University of Illinois Affiliated Hospital System
Chicago, IllinoisCorporate Governance Certificate
UCLA Anderson School of Management
Skills
- Organizational strategy development
- Risk management strategies
- Technology integration expertise
- Collaborative approach
Accomplishments
- Achieved [Result] by completing [Task] with accuracy and efficiency.
- Resolved product issue through consumer testing.
Affiliations
- FDA CDRH Advisory Panel Member (Industry Rep) 2022-present
- Board Member – B Braun Medical Inc. 2017-2024
- Board Member – Medical Device Innovation Consortium (MDIC) 2021-2024
- Board Member - American Foundation for Pharmaceutical Education 2010-2012
- Advisory Board Member – GlaxoSmithKline (US & UK) 2012-2015
- American Academy of Family Practice
- Accreditation Council for Medical Affairs
- American College of Clinical Pharmacology
- American Society for Clinical Pharmacology and Therapeutics
- Canadian Society for Clinical Pharmacology
- Nonprescription Drug Manufacturers Association (CHPA)
- Drug Information Association
- College of Physician Executives
- Gerson Lehrman Group, Inc., Healthcare & Biomedical Council
- Reviewer - Journal of Wound Care, London England
Certification
- Medical License - Illinois - Inactive
Timeline
Senior Consultant & Fractional/Contract Resource
Wes Cetnarowski MD
07.2024 - Current
Senior Vice President Scientific Affairs, Chief Medical Officer
BBraun Medical Inc., Aesculap Inc., and CAPS Pharmacies
01.2014 - 06.2024
Senior Vice President, Global Research & Development
Bayer HealthCare, Specialty Pharma & Consumer Care
01.2006 - 01.2013
Vice President Medical Affairs
Allergan, LLC
01.2000 - 01.2006
Senior Medical Director & Global Head - Dermatology, Gastroenterology, Complementary Medicine and Rx-OTC Compounds
Warner Lambert Company
01.1992 - 01.2000
Board Eligible
American Academy of Family Practice
Board Certified in Pharmaceutical Medical Affairs
Accreditation Council for Medical Affairs
undefined
Bachelor of Science - Pre-med studies
McMaster University
MD -
American University of The Caribbean (AUC)
Master of Science - Clinical Internship
University of Illinois Affiliated Hospital System
Master of Science - Family Practice Residency
University of Illinois Affiliated Hospital System
Corporate Governance Certificate
UCLA Anderson School of Management